Search fresh public links, source activity, and ready-to-use post angles for Biosimilars.
Fresh curated links around biosimilars are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
(StatePoint) Biological drug products (biologics) — which can be made of sugars, proteins, living cells, tissues, or a combination of these — are providing new options for patients...
There are no biosimilar drugs in development for 90% of biologic products set to lose their patent exclusivity by 2034, according to a report released Thursday by the Association f...
Nothing to See Here: FDA Issues Interchangeable Biosimilars Strategy Document Anonymous (not verified) Fri, 09/25/2026 - 00:58 pharmagather item url Nothin...
Biological drugs, or biologics, are now a well-established class of therapeutic products worldwide. Unlike conventional small-molecule drugs, which are generally obtained through c...
By Sara W. Koblitz —
Key Update The Biosimilars Access and Affordability Act has been reintroduced in both chambers, which would create clearer criteria for delaying Medicare price negotiation of a re...
By Bryce Platt, PharmD For more than a decade, the answer to “Where do drug wholesalers make their money?” has been generic drugs. Although wholesaler revenues are linked mo...
This GEN Spotlight on Biologics Standards for Innovation, Quality and Access brings together experts from across biopharma, standards development, and analytical science to examine...
By Tyler Novotny and Bryce Platt PBM-affiliated private label biosimilars would seem to have a built-in formulary advantage. But for ustekinumab, that advantage has not carrie...
Okuda DT, Anderson BJ, Taylor SM, Jones-McCreary MC, Burgess KW, Wright CM, Santoyo JR, Sguigna PV, Stüve O, Tran DH, Light DY, Moog TM, Punnen TG. Comparative multi-analyte serum...
Generic medications are expected to be equivalent to their brand-name counterparts — but a new study found that generic versions of certain treatments for multiple sclerosis (MS) w...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.